Changes in Biochemical Markers and Bone Mass After Withdrawal of Ibandronate Treatment: Prediction of Bone Mass Changes During Treatment

References

Page 1

	Year	Citations
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis Uri Liberman, Stuart Weiss, Johann Bröll, New England Journal of Medicine	1995	2.3K
Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis Patrick Garnero, Elisabeth Sornay‐Rendu, M. C. Chapuy, Journal of Bone and Mineral Research	1996	1K
Intermittent Cyclical Etidronate Treatment of Postmenopausal Osteoporosis Nelson B. Watts, Steven T. Harris, Harry K. Genant, New England Journal of Medicine	1990	956
Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal Osteoporosis T. Storm, Gorm Thamsborg, Torben Steiniche, New England Journal of Medicine	1990	940
Recommended Methods for the Determination of Four Enzymes in Blood R. Keiding, W. Gerhardt Denmark, E. Pitkänen, Scandinavian Journal of Clinical and Laboratory Investigation Four EnzymesEngineeringLaboratory HematologyBiochemistryScandinavian Journal	1974	848
Recommended Methods for the Determination of Four Enzymes in Blood R. Keiding, W. Gerhardt Denmark, E. Pitkänen, Scandinavian Journal of Clinical and Laboratory Investigation Four EnzymesEngineeringLaboratory HematologyBiochemistryMedicine	1974	780
Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. Patrick Garnero, W J Shih, Évelyne Gineyts, The Journal of Clinical Endocrinology & Metabolism Bone DiseaseBone HealthBone MarkersAdvanced AssaysGynecology	1994	682
The coupling of bone formation to bone resorption: A critical analysis of the concept and of its relevance to the pathogenesis of osteoporosis A. M. Parfitt Metabolic Bone Disease and Related Research MechanobiologyBone DiseaseMedicineBone RemodelingOsteoarthritis	1982	396
Bone turnover in postmenopausal osteoporosis. Effect of calcitonin treatment. Roberto Civitelli, Stefano Gonnelli, F Zacchei, Journal of Clinical Investigation	1988	362
Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy Steven T. Harris, Nelson B. Watts, Rebecca D. Jackson, The American Journal of Medicine Bone DiseaseBone HealthOpen TherapyOsteopathyBlinded Therapy	1993	355

Page 1